| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Harpoon Therapeutics Inc (NASDAQ: HARP)
HARP Technical Analysis
5
| As on 9th Jun 2023 HARP STOCK Price closed @ 0.73 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.05 & Strong Sell for SHORT-TERM with Stoploss of 5.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HARPSTOCK Price
| Open | 0.76 | Change | Price | % |
| High | 0.79 | 1 Day | -0.04 | -5.19 |
| Low | 0.73 | 1 Week | 0.07 | 10.61 |
| Close | 0.73 | 1 Month | 0.16 | 28.07 |
| Volume | 69900 | 1 Year | -6.17 | -89.42 |
| 52 Week High 8.08 | 52 Week Low 0.55 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HARP Daily Charts |
HARP Intraday Charts |
Whats New @ Bazaartrend |
HARP Free Analysis |
|
|
HARP Important Levels Intraday
| RESISTANCE | 0.85 |
| RESISTANCE | 0.81 |
| RESISTANCE | 0.79 |
| RESISTANCE | 0.76 |
| SUPPORT | 0.70 |
| SUPPORT | 0.67 |
| SUPPORT | 0.65 |
| SUPPORT | 0.61 |
HARP Forecast May 2024
| 4th UP Forecast | 7.42 |
| 3rd UP Forecast | 5.27 |
| 2nd UP Forecast | 3.95 |
| 1st UP Forecast | 2.62 |
| 1st DOWN Forecast | -1.16 |
| 2nd DOWN Forecast | -2.49 |
| 3rd DOWN Forecast | -3.81 |
| 4th DOWN Forecast | -5.96 |
HARP Weekly Forecast
| 4th UP Forecast | 2.79 |
| 3rd UP Forecast | 2.13 |
| 2nd UP Forecast | 1.72 |
| 1st UP Forecast | 1.31 |
| 1st DOWN Forecast | 0.15 |
| 2nd DOWN Forecast | -0.26 |
| 3rd DOWN Forecast | -0.67 |
| 4th DOWN Forecast | -1.33 |
HARP Forecast2024
| 4th UP Forecast | 15.49 |
| 3rd UP Forecast | 10.76 |
| 2nd UP Forecast | 7.83 |
| 1st UP Forecast | 4.9 |
| 1st DOWN Forecast | -3.44 |
| 2nd DOWN Forecast | -6.37 |
| 3rd DOWN Forecast | -9.3 |
| 4th DOWN Forecast | -14.03 |
Harpoon Therapeutics Inc ( NASDAQ USA Symbol : HARP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HARP Business Profile
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cell activating construct (TriTAC) product candidate is HPN424, which is in Phase I/IIa clinical trials for the treatment of metastatic castration-resistant prostate cancer. It is also developing HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian cancer and other mesothelin-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN328, a product candidate in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate our proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. Address: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service